Formation and treatment of cerebral edema.
D000450:Aldosterone / Q000627:therapeutic use; D000818:Animals; D001812:Blood-Brain Barrier; D001929:Brain Edema / Q000188:drug therapy / Q000209:etiology / Q000628:therapy; D001930:Brain Injuries / Q000150:complications; D003907:Dexamethasone / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D006931:Hyperbaric Oxygenation; D007023:Hypotension, Controlled; D007275:Injections, Intravenous; D008353:Mannitol / Q000008:administration & dosage; D013012:Sorbitol / Q000008:administration & dosage; D013148:Spironolactone / Q000627:therapeutic use; D013997:Time Factors
D013148:Spironolactone; D008353:Mannitol; D000450:Aldosterone; D013012:Sorbitol; D005665:Furosemide; D003907:Dexamethasone; D004976:Ethacrynic Acid